Th e present Editorial is a refl ection from the article by Stephen Manning (1) and by Sridhar Gumpeny and Lakshmi Gumpeny (2) published in this volume of Adipobiology. Focusing to injured Homo obesus (1) and glucose and energy homeostasis (2), the authors also discussed adipose-and bone-derived endocrine proteins collectively termed adipokines and osteokines, respectively.
. Schematic illustration of a "multicrine cell". The arrows, left from up-to-down, indicate endocrine, paracrine and autocrine pathway; other two arrows show exosomes and ectosomes. The arrow targeted the nucleus indicates an intracrine pathway
Adipose tissue and adipokines
Th e most momentous challenge that has occurred in the end of 1994 has been the discovery of leptin, an adipocyte-secreted Ob gene-encoded protein (9) . Th is became an acute trigger for the current development of adipobiology, particularly the studies on adipose-derived signaling protein designated adipokines (8, (10) (11) (12) (13) (14) . (16, 17) and circulating immune cells (18, 19) being introduced into the DNES. The pro-opiomelanocortin (POMC) gene encodes a family of peptides originally identified in the pituitary gland. An important POMC-derived peptide hormone, corticotropin (ACTH), is also produced by leukocytes (18) .
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Heart and cardiokines
Knowledge of the cardiac endocrine function was initiated with the discovery of "specific granules" found in the atrial cardiomyocytes of experimental animals examined with transmission electron microscope by Jemieson and Palade (20) . Onward, the granules' content was found to consist of two different peptides with similar biological effects: A-and B-type natriuretic peptides (21).
Gut and enterokines
Certain intestinal mucosal cells synthesize and release hormones (enterokines) termed incretins. These include glucagonlike peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), both of which promote proliferation of pancreatic beta cells and prevent their apoptosis (22) . Incretins also contribute to insulin secretion from the beginning of a meal and their effects are progressively amplified as plasma glucose concentrations rise. The current interest in these enterokines is due to the fact that their effects are severely reduced or absent in patients with type 2 diabetes mellitus, thus representing a novel therapeutic target for this disease (23, 24) .
Skeletal muscles and myokines
Recently, skeletal muscles -in response to contraction -also "became" an endocrine gland. They produce and release interleukin-6 (IL-6), IL-15 and adiponectin (25) (26) (27) (28) (29) (30) , leukemia inhibitory factor (31, as a paracrine signal), BDNF (32, 33) and myostatin, or growth differentiation factor 8 (GDF-8) (34) . These molecules are collectively termed myokines. Accumulating findings suggest that myokines may exert specific effects on adipose tissue as well as mediating anti-inflammatory, anti-obesogenic and insulin-sensitizing effects.
Skeleton and osteokines
The skeleton has recently emerged as an endocrine organ with effects on body weight control and glucose homeostasis through the actions of bone-derived signaling protein (osteokines) such as osteocalcin and osteopontin (1, 2, 35, 36) . The cross-talk between the adipose tissue and the skeleton constitutes a homeostatic feedback system operating with osteokines and adipokines in a bone-adipose axis (35, 36) .
Altogether, the human body may be considered a multicrine gland delivering a large number of peptides and proteins (also steroids and other signaling molecules) which control a large scale of biological processes in health and disease. 
